Root Financial Partners’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$232K Buy
+1,207
New +$130K 0.01% 389
2026
Q2
– Sell
-439
Closed -$22.3K – 2111
2026
Q1
$22.3K Buy
439
+344
+362% +$16K ﹤0.01% 1258
2025
Q4
$2.8K Sell
95
-77
-45% -$2.09K ﹤0.01% 1921
2025
Q3
$4.44K Buy
+172
New +$4.8K ﹤0.01% 1772

Other funds holding MRNA

Root Financial Partners's MRNA Position: Q3 2026 in Review

Root Financial Partners opened a new position in Moderna (MRNA) in Q3 2026: 1,207 shares worth $232K. The stake represents 0.01% of the portfolio and ranks #389 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in MRNA as recently as Q1 2026.

Root Financial Partners first reported a position in MRNA in Q3 2025 and has held it in 4 quarters since. 693 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Root Financial Partners held 1,207 shares of Moderna worth $232K as of Q3 2026.
  • Moderna was a new Root Financial Partners position in Q3 2026.
  • Moderna made up 0.01% of Root Financial Partners's portfolio in Q3 2026, its #389 holding.
  • Root Financial Partners first reported a position in Moderna in Q3 2025 and has held it in 4 quarters since.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.